GSK-LSD1 2HCL
1431368-48-7
|
GSK-LSD1 Dihydrochloride
2102933-95-7
|
GSK-LSD1 dihydrochloride
1821798-25-7
|
GSK J5 HCl
1797983-32-4
|
GSK-J4
1373423-53-0
|
GSK 2033
1221277-90-2
|
GSK 2018682
1034688-30-6
|
GSK-3β inhibitor 3
1448990-73-5
|
GSK 269962
850664-21-0
|
2,5-diethoxy-N-(3-ethoxypropyl)-4-methylbenzenesulfonamide
942667-42-7
|
4-ethoxy-N-(3-ethoxypropyl)naphthalene-1-sulfonamide
942703-11-9
|
7-Bromo-3,3-dimethyl-2,3-dihydrobenzofuran-5-carboxylic acid
532440-91-8
|
6-{[(3-Methoxypropyl)amino]sulfonyl}chromen-2-one
942772-04-5
|
6-{[(2-Methoxyethyl)amino]sulfonyl}chromen-2-one
942667-45-0
|
N,N-bis(2-hydroxyethyl)-2,4,5-trimethylbenzenesulfonamide
942703-14-2
|
[(3,4-Dichloro-2-methoxyphenyl)sulfonyl]bis(2-hydroxyethyl)amine
942789-25-5
|
Bis(2-hydroxyethyl)[(4-chloro-2,5-dimethoxyphenyl)sulfonyl]amine
942772-07-8
|
Bis(2-hydroxyethyl)[(4-bromo-2,5-dimethoxyphenyl)sulfonyl]amine
942667-48-3
|
Bis(2-hydroxyethyl)[(2,5-dimethoxy-4-methylphenyl)sulfonyl]amine
942703-17-5
|
